Use in combination with a XOi for the treatment of hyperuricemia associated with gout in patients who have not achieved target serum uric acid levels with a xanthine oxidase inhibitor alone. Not recommended for the treatment of asymptomatic hyperuricemia. Should not be used as monotherapy. The gene discussed is XDH; the disease is gout.